The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies
Clinical trial NCT04097769 · COMPLETED
Trial details
- NCT number
- NCT04097769
- Sponsor
- Waterstone Hanxbio Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2021-03-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.